Articles with public access mandates - alastair m thompsonLearn more
Not available anywhere: 22
Operative and oncologic outcomes in 9861 patients with operable breast cancer: single-institution analysis of breast conservation with oncoplastic reconstruction
SA Carter, GR Lyons, HM Kuerer, RL Bassett, S Oates, A Thompson, ...
Annals of surgical oncology 23, 3190-3198, 2016
Mandates: US National Institutes of Health
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase
E Rutgers, MJ Piccart-Gebhart, J Bogaerts, S Delaloge, L Van‘t Veer, ...
European journal of cancer 47 (18), 2742-2749, 2011
Mandates: US National Institutes of Health, Cancer Research UK
Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
SM Hadad, DG Hardie, V Appleyard, AM Thompson
Clinical and Translational Oncology 16, 746-752, 2014
Mandates: Cancer Research UK, National Institute for Health Research, UK
Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer
AM Thompson, T Rapson, FJ Gilbert, KGM Park
Journal of British Surgery 94 (5), 578-584, 2007
Mandates: Chief Scientist Office, Scottish Executive
Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model
MVCL Appleyard, MA O'Neill, KE Murray, FEM Paulin, SE Bray, ...
International journal of cancer 124 (2), 465-472, 2009
Mandates: Cancer Research UK
Macroscopic handling and reporting of breast cancer specimens pre‐and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches
SE Pinder, EA Rakha, CA Purdie, JMS Bartlett, A Francis, RC Stein, ...
Histopathology 67 (3), 279-293, 2015
Mandates: National Institute for Health Research, UK
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: findings from the Sloane Project
AJ Maxwell, K Clements, DJ Dodwell, AJ Evans, A Francis, M Hussain, ...
The Breast 27, 109-115, 2016
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
F Cardoso, M Saghatchian, A Thompson, E Rutgers
Journal of clinical oncology 26 (12), 2058-2059, 2008
Mandates: US National Institutes of Health
Functional tumor volume by fast dynamic contrast‐enhanced MRI for predicting neoadjuvant systemic therapy response in triple‐negative breast cancer
BC Musall, AH Abdelhafez, BE Adrada, RP Candelaria, RMM Mohamed, ...
Journal of Magnetic Resonance Imaging 54 (1), 251-260, 2021
Mandates: US National Institutes of Health
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery
A Bartram, F Gilbert, A Thompson, GB Mann, A Agrawal
Cancer treatment reviews 94, 102158, 2021
Mandates: National Institute for Health Research, UK
Archival single-cell genomics reveals persistent subclones during DCIS progression
K Wang, T Kumar, J Wang, DC Minussi, E Sei, J Li, TM Tran, ...
Cell 186 (18), 3968-3982. e15, 2023
Mandates: US Department of Defense, US National Institutes of Health, Cancer Research …
Clinical translation and evaluation of a handheld and biocompatible mass spectrometry probe for surgical use
J Zhang, M Sans, RJ DeHoog, KY Garza, ME King, CL Feider, ...
Clinical chemistry 67 (9), 1271-1280, 2021
Mandates: US National Institutes of Health, Gordon and Betty Moore Foundation
Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II to III HER-2/neu-positive breast cancer: a retrospective, single institution …
RK Murthy, AS Raghavendra, KR Hess, T Fujii, B Lim, CH Barcenas, ...
Clinical breast cancer 18 (6), e1283-e1288, 2018
Mandates: US National Institutes of Health
OncotypeDX recurrence score does not predict nodal burden in clinically node negative breast cancer patients
SE Tevis, R Bassett, I Bedrosian, CH Barcenas, DM Black, AS Caudle, ...
Annals of surgical oncology 26, 815-820, 2019
Mandates: US National Institutes of Health
Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right
A Francis, J Bartlett, D Rea, SE Pinder, RC Stein, H Stobart, CA Purdie, ...
European Journal of Surgical Oncology (EJSO) 42 (7), 994-998, 2016
Mandates: National Institute for Health Research, UK
Effects of standard treatments for ductal carcinoma in situ—making informed choices
L Fallowfield, A Francis, AM Thompson
JAMA oncology 2 (3), 396-397, 2016
Mandates: US National Institutes of Health
Are baseline mammographic and ultrasound features associated with metastasis free survival in women receiving neoadjuvant chemotherapy for invasive breast cancer?
A Evans, YT Sim, P Whelehan, S Savaridas, L Jordan, A Thompson
European Journal of Radiology 141, 109790, 2021
Mandates: Breast Cancer Now, UK
Locoregional breast cancer recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: analysis of risk factors including the 70 …
S Alaeikhanehshir, T Ajayi, FH Duijnhoven, C Poncet, RO Olaniran, ...
Journal of Clinical Oncology 42 (10), 1124-1134, 2024
Mandates: Cancer Research UK
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy
N Abuhadra, R Sun, RL Bassett Jr, L Huo, JT Chang, M Teshome, ...
Investigational New Drugs 41 (3), 391-401, 2023
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer
W Treekitkarnmongkol, V Shah, K Kai, H Katayama, J Wong, FA Ladha, ...
British journal of cancer, 1-13, 2024
Mandates: Cancer Research UK
Publication and funding information is determined automatically by a computer program